Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × anlotinib × Clear all

NCT02461407 2017-12-29

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms